<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>LA082989-0088</title>
	</head>
	<body>
		<main>
			<p><P> August 29, 1989, Tuesday, Home Edition  </P> <P> EARNINGS  </P> <P> Whittaker Corp.: The Los Angeles-based aerospace and biotechnology company,  which is restructuring and selling some operations, reported a $2.6-million  loss from continuing operations in the third quarter ended July 31, contrasted  with profit of $2.2 million in the same period last year. Income from  continuing operations was reduced by a non-recurring pretax charge of $10.2  million, which included $6.4 million in expenses "incurred in various efforts  to maximize shareholder value, including efforts to sell the company" as well  as $3.8 million for canceling employee stock options as part of Whittaker's  recapitalization. Operating profit from continuing operations for the quarter  rose 41.5% to $10.5 million. Sales increased 1.9% to $50.8 million. Whittaker  reported a negative shareholders equity of $57.8 million on July 31 because it  charged to equity the $280.9 million in cash paid to shareholders as part of  the restructuring and $2.8 million in expenses from the recapitalization.  </P></p>
		</main>
</body></html>
            